Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults

Fourth edition

on behalf of the International Headache Society Clinical Trials Standing Committee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.

Original languageEnglish (US)
JournalCephalalgia
DOIs
StatePublished - Jan 1 2019

Fingerprint

Migraine Disorders
Headache
Clinical Trials
Guidelines
Headache Disorders
Pharmaceutical Preparations
Therapeutics
Randomized Controlled Trials
Medicine
Equipment and Supplies

Keywords

  • acute treatment of migraine attacks in adults
  • controlled trials
  • Guidelines

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults : Fourth edition. / on behalf of the International Headache Society Clinical Trials Standing Committee.

In: Cephalalgia, 01.01.2019.

Research output: Contribution to journalArticle

on behalf of the International Headache Society Clinical Trials Standing Committee. / Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults : Fourth edition. In: Cephalalgia. 2019.
@article{bc4aebe9be2442bfaa7ab47bf5824693,
title = "Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition",
abstract = "The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.",
keywords = "acute treatment of migraine attacks in adults, controlled trials, Guidelines",
author = "{on behalf of the International Headache Society Clinical Trials Standing Committee} and Diener, {Hans Christoph} and Cristina Tassorelli and Dodick, {David W.} and Silberstein, {Stephen D.} and Lipton, {Richard B.} and Messoud Ashina and Becker, {Werner J.} and Ferrari, {Michel D.} and Goadsby, {Peter J.} and Patricia Pozo-Rosich and Wang, {Shuu Jiun} and Jay Mandrekar",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/0333102419828967",
language = "English (US)",
journal = "Cephalalgia",
issn = "0333-1024",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults

T2 - Fourth edition

AU - on behalf of the International Headache Society Clinical Trials Standing Committee

AU - Diener, Hans Christoph

AU - Tassorelli, Cristina

AU - Dodick, David W.

AU - Silberstein, Stephen D.

AU - Lipton, Richard B.

AU - Ashina, Messoud

AU - Becker, Werner J.

AU - Ferrari, Michel D.

AU - Goadsby, Peter J.

AU - Pozo-Rosich, Patricia

AU - Wang, Shuu Jiun

AU - Mandrekar, Jay

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.

AB - The quality of clinical trials is an essential part of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for controlled trials of drugs in migraine. Scientific and clinical developments in headache medicine led to second and third editions in 2000 and 2012, respectively. The current, fourth edition of the Guidelines retains the structure and much content from previous editions. However, it also incorporates evidence from clinical trials published after the third edition as well as feedback from meetings with regulators, pharmaceutical and device manufacturers, and patient associations. Its final form reflects the collective expertise and judgement of the Committee. These updated recommendations and commentary are intended to meet the Society's continuing objective of providing a contemporary, standardized, and evidence-based approach to the conduct and reporting of randomised controlled trials for the acute treatment of migraine attacks.

KW - acute treatment of migraine attacks in adults

KW - controlled trials

KW - Guidelines

UR - http://www.scopus.com/inward/record.url?scp=85062349317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062349317&partnerID=8YFLogxK

U2 - 10.1177/0333102419828967

DO - 10.1177/0333102419828967

M3 - Article

JO - Cephalalgia

JF - Cephalalgia

SN - 0333-1024

ER -